IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines

Cytokine

Volumn 49, Issue 3, 2010, Pages 294-302

  Zeng, Li ^a   O'Connor, Colleen ^a   Zhang, Jiayou ^a   Kaplan, Alan M ^a   Cohen, Donald A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Cancer; Interleukin 10; Metastasis; Non small cell lung carcinoma

Indexed keywords

CD31 ANTIGEN; INTERLEUKIN 10; OVALBUMIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL INFILTRATION; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LEWIS CARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STABLE TRANSFECTION; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VASCULARIZATION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CHICKENS; HUMANS; INTERLEUKIN-10; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-10; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE;

EID: 75449085685     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.11.015     Document Type: Article

References (71)

1. De Vita F., Orditura M., Galizia G., Romano C., Roscigno A., Lieto E., et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 117 (2000) 365-373
2. Bansal A.S., Bruce J., Devine P.L., Scells B., and Zimmermann P.V. Serum cytokines and tumour markers in patients with non-small cell carcinoma of the lung. Dis Markers 13 (1997) 195-199
3. Hatanaka H., Abe Y., Kamiya T., Morino F., Nagata J., Tokunaga T., et al. Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol 11 (2000) 815-819
4. Hatanaka H., Abe Y., Naruke M., Tokunaga T., Oshika Y., Kawakami T., et al. Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. Clin Cancer Res 7 (2001) 1287-1292
5. Naruke M., Abe Y., Hatanaka H., Ohnishi Y., Yamazaki H., Kijima H., et al. Interleukin-10 expression is correlated with growth fraction in human non-small cell lung cancer xenografts. Int J Oncol 18 (2001) 1213-1217
6. Huang M., Sharma S., Mao J.T., and Dubinett S.M. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157 (1996) 5512-5520
7. Nakamura H., Kawasaki N., Hagiwara M., Saito M., Konaka C., and Kato H. Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung cancer 28 (2000) 139-145
8. Garcia-Hernandez M.L., Hernandez-Pando R., Gariglio P., and Berumen J. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology 105 (2002) 231-243
9. Gu Z.J., Costes V., Lu Z.Y., Zhang X.G., Pitard V., Moreau J.F., et al. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 88 (1996) 3972-3986
10. Lu Z.Y., Zhang X.G., Rodriguez C., Wijdenes J., Gu Z.J., Morel-Fournier B., et al. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 85 (1995) 2521-2527
11. Sredni B., Weil M., Khomenok G., Lebenthal I., Teitz S., Mardor Y., et al. Ammonium trichloro(dioxoethylene-o, o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res 64 (2004) 1843-1852
12. Stassi G., Todaro M., Zerilli M., Ricci-Vitiani L., Di Liberto D., Patti M., et al. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer res 63 (2003) 6784-6790
13. Yen Chong S., Lin Y.C., Czarneski J., Zhang M., Coffman F., Kashanchi F., et al. Cell cycle effects of IL-10 on malignant B-1 cells. Genes Immun 2 (2001) 239-247
14. Yue F.Y., Dummer R., Geertsen R., Hofbauer G., Laine E., Manolio S., et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 71 (1997) 630-637
15. Moore M.W., Carbone F.R., and Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54 (1988) 777-785
16. Euhus D.M., Hudd C., LaRegina M.C., and Johnson F.E. Tumor measurement in the nude mouse. J Surg Oncol 31 (1986) 229-234
17. Gerber S.A., Moran J.P., Frelinger J.G., Frelinger J.A., Fenton B.M., and Lord E.M. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. Br J Cancer 88 (2003) 1453-1461
18. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
19. Fine J.S., Rojas-Triana A., Jackson J.V., Engstrom L.W., Deno G.S., Lundell D.J., et al. Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation 27 (2003) 161-174
20. Lisinski T.J., and Furie M.B. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J Leukoc Biol 72 (2002) 503-511
21. Meghari S., Capo C., Raoult D., and Mege J.L. Deficient transendothelial migration of leukocytes in q Fever: the role played by interleukin-10. J Infect Dis 194 (2006) 365-369
22. Nakagome K., Dohi M., Okunishi K., Komagata Y., Nagatani K., Tanaka R., et al. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J Immunol 174 (2005) 6955-6966
23. Perretti M., Szabo C., and Thiemermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol 116 (1995) 2251-2257
24. Vicioso M.A., Garaud J.J., Reglier-Poupet H., Lebeaut A., Gougerot-Pocidalo M.A., and Chollet-Martin S. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. Eur Cytokine Netw 9 (1998) 247-253
25. Beatty P.R., Krams S.M., and Martinez O.M. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 158 (1997) 4045-4051
26. Jones K.D., Aoki Y., Chang Y., Moore P.S., Yarchoan R., and Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94 (1999) 2871-2879
27. Otsuki T., Yata K., Sakaguchi H., Uno M., Fujii T., Wada H., et al. IL-10 in myeloma cells. Leuk Lymphoma 43 (2002) 969-974
28. Peng B., Mehta N.H., Fernandes H., Chou C.C., and Raveche E. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leuk Res 19 (1995) 159-167
29. Tuyt L.M., Dokter W.H., Esselink M.T., and Vellenga E. Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells. Eur Cytokine Netw 6 (1995) 231-235
30. Visser H.P., Tewis M., Willemze R., and Kluin-Nelemans J.C. Mantle cell lymphoma proliferates upon IL-10 in the CD40 system. Leukemia 14 (2000) 1483-1489
31. Fiehn C., Paleolog E.M., and Feldmann M. Selective enhancement of endothelial cell VCAM-1 expression by interleukin-10 in the presence of activated leucocytes. Immunology 91 (1997) 565-571
32. Kohno T., Mizukami H., Suzuki M., Saga Y., Takei Y., Shimpo M., et al. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res 63 (2003) 5091-5094
33. Sironi M., Munoz C., Pollicino T., Siboni A., Sciacca F.L., Bernasconi S., et al. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 23 (1993) 2692-2695
34. Vora M., Romero L.I., and Karasek M.A. Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 184 (1996) 821-829
35. Hashimoto T., Nakamura M., Oshika Y., Tsuchida T., Yamazaki H., Kijima H., et al. Interleukin-10 relieves the inhibitory effects of interferon-gamma on normal human lung fibroblasts. Int J Mol Med 7 (2001) 149-154
36. Moroguchi A., Ishimura K., Okano K., Wakabayashi H., Maeba T., and Maeta H. Interleukin-10 suppresses proliferation and remodeling of extracellular matrix of cultured human skin fibroblasts. Eur Surg Res 36 (2004) 39-44
37. Reitamo S., Remitz A., Tamai K., and Uitto J. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest 94 (1994) 2489-2492
38. Seitz M., Loetscher P., Dewald B., Towbin H., Gallati H., and Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 25 (1995) 1129-1132
39. Yamamoto T., Eckes B., and Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun 281 (2001) 200-205
40. Wojciechowska-Lacka A., Matecka-Nowak M., Adamiak E., Lacki J.K., and Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 43 (1996) 155-158
41. Huang S., Ullrich S.E., and Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res 19 (1999) 697-703
42. Walos S., Szary J., and Szala S. Inhibition of tumor growth by interleukin 10 gene transfer in B16(F10) melanoma cells. Acta Biochim Pol 46 (1999) 967-970
43. Todaro M., Zerilli M., Ricci-Vitiani L., Bini M., Perez Alea M., Maria Florena A., et al. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 66 (2006) 1491-1499
44. Stearns M.E., Kim G., Garcia F., and Wang M. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 cells. Mol Cancer Res 2 (2004) 403-416
45. Stearns M.E., Garcia F.U., Fudge K., Rhim J., and Wang M. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 5 (1999) 711-720
46. Srendi B. AS101 sensitizes tumors to chemotherapy bu inhibiting the tumor IL-10 autocrine loop. Cancer Res (2004) 1843-1852
47. Rico M.J., Matar P., Gervasoni S.I., Bonfil R.D., Calcaterra N., and Scharovsky O.G. The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion. Clin Exp Metastasis 22 (2005) 127-135
48. Naruke M. IL-10 Expression is Correlated with Growth Fraction in Human NSCLC Xenografts. Int J Oncol 18 (2001) 1213-1217
49. Huettner C., Czub S., Kerkau S., Roggendorf W., and Tonn J.C. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 17 (1997) 3217-3224
50. Huang M. NSCLC derived soluble mediators and prostaglanding E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157 (1996) 5512-5520
51. De Vleeschouwer S., Spencer Lopes I., Ceuppens J.L., and Van Gool S.W. Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells. J Neurooncol 84 (2007) 131-140
52. Jarnicki A.G., Lysaght J., Todryk S., and Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 177 (2006) 896-904
53. Ke Y., Kapp L.M., and Kapp J.A. Inhibition of tumor rejection by gammadelta T cells and IL-10. Cell Immunol 221 (2003) 107-114
54. Sharma S., Stolina M., Lin Y., Gardner B., Miller P.W., Kronenberg M., et al. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol 163 (1999) 5020-5028
55. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., van Damme J., et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J Immunol 164 (2000) 762-767
56. Groux H., Bigler M., de Vries J.E., and Roncarolo M.G. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 160 (1998) 3188-3193
57. Oshima K., Cui G., Tung T., Okotie O., Laks H., and Sen L. Exogenous IL-10 overexpression reduces perforin production by activated allogenic CD8+ cells and prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 292 (2007) H277-H284
58. Lee H.S., Wang Y., Maciejewski B.S., Esho K., Fulton C., Sharma S., et al. Interleukin-10 protects cultured fetal rat type II epithelial cells from injury induced by mechanical stretch. Am J Physiol Lung Cell Mol Physiol 294 (2008) L225-L232
59. Todaro M., Zerilli M., Ricci-Vitiani L., Bini M., Perez Alea M., Maria Florena A., et al. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 66 (2006) 1491-1499
60. Ziege S.U., Geerdes-Fenge H.F., Rau M., Buchwald U., and Lode H. In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes. Eur J Med Res 5 (2000) 369-374
61. Di Carlo E., Coletti A., Modesti A., Giovarelli M., Forni G., and Musiani P. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur Cytokine Netw 9 (1998) 61-68
62. Huang S., Xie K., Bucana C.D., Ullrich S.E., and Bar-Eli M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res 2 (1996) 1969-1979
63. Silvestre J.S., Mallat Z., Duriez M., Tamarat R., Bureau M.F., Scherman D., et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 87 (2000) 448-452
64. Kitabayashi A., Hirokawa M., and Miura A.B. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int J Hematol 62 (1995) 99-106
65. Turina M., Hoth J.J., Turpen R.M., Scott M.J., and Cheadle W.G. Alveolar interleukin-10 regulates neutrophil apoptosis in severely traumatized patients. J Trauma 63 (2007) 733-739
66. Zhang L., Wang X., Zheng W., and Shi M. The effects of interleukin-10 on the expression of Fas and FasL in rat hepatic stellate cells. Med Chem 2 (2006) 611-616
67. Arimoto T., Choi D.Y., Lu X., Liu M., Nguyen X.V., Zheng N., Stewart C.A., Kim H.C., and Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging (2006)
68. Santiago-Lomeli M., Gomez-Quiroz L.E., Ortiz-Ortega V.M., Kershenobich D., and Gutierrez-Ruiz M.C. Differential effect of interleukin-10 on hepatocyte apoptosis. Life Sci 76 (2005) 2569-2579
69. Boyd Z.S., Kriatchko A., Yang J., Agarwal N., Wax M.B., and Patil R.V. Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest Ophthalmol Vis Sci 44 (2003) 5206-5211
70. Oshima K., Laks H., Cui G., Tung T., Sacks B.M., Kruse A.A., et al. Interleukin-10 gene targeting induced apoptosis of alloractive T cell via FAS/FASL pathway. J Heart Lung Transplant 20 (2001) 220-221
71. Deng J., Kohda Y., Chiao H., Wang Y., Hu X., Hewitt S.M., et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 60 (2001) 2118-2128